[ad_1] Brendan Kennedy, CEO of Tilray, told CNRA on Tuesday that pharmaceutical companies had to start thinking of partnering with cannabis companies as a "hedge" against the flourishing marijuana industry.
Read More »Invest in the "big blanket" for alcohol
